Authors:
Wanebo, H
Chougule, P
Ready, N
Safran, H
Ackerley, W
Koness, RJ
McRae, R
Nigri, P
Leone, L
Radie-Keane, K
Reiss, P
Kennedy, T
Citation: H. Wanebo et al., Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer ofthe head and neck (stage III and IV), ANN SURG O, 8(8), 2001, pp. 644-650
Authors:
Safran, H
Moore, T
Iannitti, D
Dipetrillo, T
Akerman, P
Cioffi, W
Harrington, D
Quirk, D
Rathore, R
Cruff, D
Vakharia, J
Vora, S
Savarese, D
Wanebo, H
Citation: H. Safran et al., Paclitaxel and concurrent radiation for locally advanced pancreatic cancer, INT J RAD O, 49(5), 2001, pp. 1275-1279
Authors:
Mehta, S
Blackinton, D
Omar, I
Kouttab, N
Myrick, D
Klostergaard, J
Wanebo, H
Citation: S. Mehta et al., Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line, CANC CHEMOT, 46(2), 2000, pp. 85-92
Authors:
Safran, H
Akerman, P
Cioffi, W
Gaissert, H
Joseph, P
King, T
Hesketh, PJ
Wanebo, H
Citation: H. Safran et al., Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction, SEM RAD ONC, 9(2), 1999, pp. 53-57
Authors:
Myrick, D
Blackinton, D
Klostergaard, J
Kouttab, N
Maizel, A
Wanebo, H
Mehta, S
Citation: D. Myrick et al., Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide, LEUK RES, 23(6), 1999, pp. 569-578